Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 013174

« Back to Dashboard

NDA 013174 describes DYRENIUM, which is a drug marketed by Concordia Pharms Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the DYRENIUM profile page.

The generic ingredient in DYRENIUM is triamterene. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the triamterene profile page.
Summary for 013174
Applicant:Concordia Pharms Inc
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 013174
Medical Subject Heading (MeSH) Categories for 013174
Suppliers and Packaging for NDA: 013174
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DYRENIUM triamterene CAPSULE;ORAL 013174 NDA Concordia Pharmaceuticals Inc. 59212-002 N 59212-002-01
DYRENIUM triamterene CAPSULE;ORAL 013174 NDA Concordia Pharmaceuticals Inc. 59212-003 N 59212-003-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.